Posaconazole for chronic pulmonary aspergillosis: The next strategy against the threat of azole-resistant Aspergillus infection

Clinical Infectious Diseases

Volumn 51, Issue 12, 2010, Pages 1392-1394

  Kohno, Shigeru ^a   Izumikawa, Koichi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; PYRROLE; VORICONAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBODY TITER; ASPERGILLOSIS; CHRONIC LUNG ASPERGILLOSIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG SENSITIVITY; HUMAN; LUNG ASPERGILLOSIS; LUNG CAVITATION; MIXED INFECTION; NONHUMAN; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TREATMENT FAILURE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTIFUNGAL AGENTS; ASPERGILLUS; DRUG RESISTANCE, FUNGAL; HUMANS; PULMONARY ASPERGILLOSIS; TREATMENT OUTCOME; TRIAZOLES;

EID: 78649872537     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/657307     Document Type: Note

References (9)

1. Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003; 37(Suppl 3):S265-S280.
2. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46:327-360.
3. Hope WW, Walsh TJ, Denning DW. The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol 2005; 43(Suppl 1):S207-S238.
4. Felton TW, Baxter C, Moore CB, Roberts SA, Hope WW, Denning DW. Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. Clin Infect Dis 2010; 51(12):1383-1391 (in this issue).
5. Izumikawa K, Takazono T, Kohno S. Chronic aspergillus infections of the respiratory tract: diagnosis, management and antifungal resistance. Curr Opin Infect Dis (in press).
6. Howard SJ, Cerar D, Anderson MJ, et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 2009; 15:1068-1076.
7. Verweij PE, Howard SJ, Melchers WJ, Denning DW. Azole-resistance in Aspergillus: proposed nomenclature and breakpoints. Drug Resist Updat 2009; 12:141-147.
8. Bellete B, Raberin H, Morel J, Flori P, Hafid J, Manhsung RT. Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma. Med Mycol 2010; 48:197-200.
9. Kohno S, Izumikawa K, Ogawa K, et al. Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan. J Infect (in press).